We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00332306
Recruitment Status : Unknown
Verified January 2009 by Tuberculosis Research Centre, India.
Recruitment status was:  Active, not recruiting
First Posted : June 1, 2006
Last Update Posted : October 8, 2009
Sponsor:
Collaborators:
National AIDS Control Organisation
Indian Council of Medical Research
Information provided by:
Tuberculosis Research Centre, India